SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice
Version 4 2020-09-15, 15:41
Version 3 2020-04-09, 13:59
Version 2 2019-02-15, 09:27
Version 1 2018-07-17, 09:50
dataset
posted on 2020-09-15, 15:41 authored by John Wilding, Kevin Fernando, Nicola Milne, Marc Evans, Amar Ali, Steve Bain, June James, Philip Newland-Jones, Dipesh Patel, Adie Viljoen<p></p><p> </p><p>The above summary slide and prescribing tool represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p><p>
</p><p>© The authors, CC-BY-NC 2020.<b> </b></p><p> </p><p></p>
History
Related Materials
- 1.
